Medidrengene ApS: Financial statements 2023
CVR: 38697722
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Medidrengene ApS (CVR 38697722) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -11,405 and a net result of DKK -11,234 compared with DKK 16,174 the year before. Equity in the 2023 report amounted to DKK 48,182. The solvency ratio was 46.6%.
- Revenue
- DKK 0
- Gross Profit
- DKK -11,405
- Profit/Loss
- DKK -11,234
- Equity
- DKK 48,182
- Total Assets
- DKK 103,429
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 0 | -11K | -11K | 48K | - |
| 2022 | 87K | 76K | 16K | 59K | - |
| 2021 | 203K | 177K | 838 | 43K | - |
| 2020 | 140K | 117K | 32K | 42K | - |
| 2019 | 160K | 131K | 9K | 11K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Medidrengene ApS has published its annual report for 2022. Revenue came to DKK 86,800, and the net result was DKK 16,174.
About Medidrengene ApS
Medidrengene ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2017. The company is registered under the industry Fotografiske aktiviteter. The company was previously named Mediedrengene IVS. The management consists of Laurits Christoffer Højbjerg Lassen and Magnus Eldrup. The company is owned by Laurits Christoffer Højbjerg Lassen and Magnus Eldrup. The company has 2 employees (2021). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -247 compared with DKK 41,365 the year before. Equity in the 2025 report amounted to DKK 40,935.